ATE434406T1 - Manganzusammensetzungen und verfahren für mri - Google Patents

Manganzusammensetzungen und verfahren für mri

Info

Publication number
ATE434406T1
ATE434406T1 AT99961531T AT99961531T ATE434406T1 AT E434406 T1 ATE434406 T1 AT E434406T1 AT 99961531 T AT99961531 T AT 99961531T AT 99961531 T AT99961531 T AT 99961531T AT E434406 T1 ATE434406 T1 AT E434406T1
Authority
AT
Austria
Prior art keywords
mri
mangale
compositions
methods
source
Prior art date
Application number
AT99961531T
Other languages
English (en)
Inventor
Peter Seoane
Phillip Harnish
Adele Vessey
Original Assignee
Eagle Vision Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eagle Vision Pharmaceutical Co filed Critical Eagle Vision Pharmaceutical Co
Application granted granted Critical
Publication of ATE434406T1 publication Critical patent/ATE434406T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
AT99961531T 1998-11-02 1999-10-26 Manganzusammensetzungen und verfahren für mri ATE434406T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/184,835 US5980863A (en) 1998-11-02 1998-11-02 Manganese compositions and methods for MRI
PCT/US1999/024993 WO2000025671A1 (en) 1998-11-02 1999-10-26 Manganese compositions and methods for mri

Publications (1)

Publication Number Publication Date
ATE434406T1 true ATE434406T1 (de) 2009-07-15

Family

ID=22678556

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99961531T ATE434406T1 (de) 1998-11-02 1999-10-26 Manganzusammensetzungen und verfahren für mri

Country Status (12)

Country Link
US (1) US5980863A (de)
EP (1) EP1126785B1 (de)
JP (1) JP4763132B2 (de)
KR (1) KR100692720B1 (de)
CN (1) CN1325286A (de)
AT (1) ATE434406T1 (de)
AU (1) AU754294B2 (de)
CA (1) CA2349342C (de)
DE (1) DE69941029D1 (de)
NO (1) NO327611B1 (de)
NZ (1) NZ511592A (de)
WO (1) WO2000025671A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE373644T1 (de) * 2002-02-05 2007-10-15 Bristol Myers Squibb Co N-substituierte 3-hydroxy-4-pyridinone und diese enthaltende pharmazeutika
US6869591B2 (en) * 2002-03-26 2005-03-22 Barnes-Jewish Hospital Paramagnetic particles that provide improved relaxivity
US7966056B2 (en) * 2002-12-16 2011-06-21 Ge Healthcare As Magnetic resonance imaging method and compounds for use in the method
US20050106100A1 (en) * 2003-09-03 2005-05-19 Harris Thomas D. Compounds containing matrix metalloproteinase substrates and methods of their use
US20050197614A1 (en) * 2004-03-04 2005-09-08 Wilson Pritchard Occlusive biomedical devices, punctum plugs, and methods of use thereof
JP2006282604A (ja) * 2005-04-01 2006-10-19 Fuji Photo Film Co Ltd 金属キレート構造を有するグリセリンエステル誘導体
CA2613439A1 (en) * 2005-06-30 2007-01-11 Bristol-Myers Squibb Pharma Company Hydrazide conjugates as imaging agents
US20080081021A1 (en) * 2006-09-29 2008-04-03 Mehmet Bilgen Manganese-enhanced magnetic resonance imaging of neurons using electrical stimulation
US8414866B2 (en) * 2007-12-17 2013-04-09 Ge Healthcare As Method of magnetic resonance imaging of the heart with paramagnetic MN2+
WO2011003818A2 (en) 2009-07-06 2011-01-13 Cmc Contrast Ab Diagnostic method
CN103656690B (zh) * 2012-09-11 2016-04-27 南京逐陆医药科技有限公司 一种氯化锰口服溶液的制备方法
KR101683635B1 (ko) 2014-12-29 2016-12-09 가천대학교 산학협력단 락테이트 금속염을 포함하는 암 치료용 약학 조성물
US10233205B2 (en) 2015-08-07 2019-03-19 Auburn University Magnetic resonance imaging contrast agent capable of detecting hydrogen peroxide and reducing reactive oxygen species
KR20250042852A (ko) 2018-01-12 2025-03-27 (주) 메티메디제약 만성 염증성 질환의 치료 방법
JP2020069470A (ja) * 2018-10-29 2020-05-07 株式会社げんてん本店 リポソームの製造方法、及び、リポソーム含有液の製造方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1965535A (en) * 1933-03-01 1934-07-03 Pfizer Charles & Co Stable calcium gluconate solution and process of making same
FR2126134A1 (en) * 1971-02-26 1972-10-06 Ates Ibrahim Cyclophosphamide/magnesium compsns - with enhanced cytostatic activity
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3316703A1 (de) * 1983-05-04 1984-11-08 Schering AG, 1000 Berlin und 4709 Bergkamen Orales kontrastmittel fuer die kernspintomographie und dessen herstellung
SE465907B (sv) * 1984-11-01 1991-11-18 Nyegaard & Co As Diagnosticeringsmedel innehaallande en paramagnetisk metall
US5082649A (en) * 1987-06-30 1992-01-21 Mallinckrodt Medical, Inc. Method for enhancing the safety of metal-ligand chelates as magnetic resonance imaging agents by addition of calcium ions
US4915933A (en) * 1986-06-26 1990-04-10 The University Of New Mexico Mixed complexes as shift and contrast reagents in NMR imaging and spectroscopy
AU608759B2 (en) * 1986-08-04 1991-04-18 Amersham Health Salutar Inc NMR imaging with paramagnetic polyvalents metal salts of poly-(acid-alkylene-amido)-alkanes
FI884376L (fi) * 1987-09-25 1989-03-26 Salutar Inc Nya mn (ii)-koordinationskompositioner vid fotografering med nmr.
US5078986A (en) * 1989-02-15 1992-01-07 Mallinckrodt Medical, Inc. Method for enhancing magnetic resonance imaging using an image altering agent containing an excess of chelating agent
US5143716A (en) * 1991-02-01 1992-09-01 Unger Evan C Phosphorylated sugar alcohols, Mono- and Di-Saccharides as contrast agents for use in magnetic resonance imaging of the gastrointestinal region
US5330742A (en) * 1991-08-05 1994-07-19 Mallinckrodt Medical, Inc. Methods and compositions for magnetic resonance imaging
US5250284A (en) * 1991-10-15 1993-10-05 Arnon Krongrad Method for increasing nuclear magnetic resonance signals in living biological tissue using zinc
US5344640A (en) * 1991-10-22 1994-09-06 Mallinckrodt Medical, Inc. Preparation of apatite particles for medical diagnostic imaging
JP2911674B2 (ja) * 1992-02-20 1999-06-23 明治乳業株式会社 消化管造影用組成物
US5401492A (en) * 1992-12-17 1995-03-28 Sterling Winthrop, Inc. Water insoluble non-magnetic manganese particles as magnetic resonance contract enhancement agents
NZ291479A (en) * 1994-08-18 1999-04-29 Nycomed Imaging As Contrast medium containing a manganese compound, an uptake promoter and carrier for use in mri
GB9416768D0 (en) * 1994-08-18 1994-10-12 Nycomed Innovation Ab Compositions

Also Published As

Publication number Publication date
EP1126785B1 (de) 2009-06-24
AU1808600A (en) 2000-05-22
EP1126785A1 (de) 2001-08-29
JP4763132B2 (ja) 2011-08-31
CN1325286A (zh) 2001-12-05
US5980863A (en) 1999-11-09
NO20011946D0 (no) 2001-04-19
CA2349342C (en) 2011-07-12
WO2000025671A1 (en) 2000-05-11
CA2349342A1 (en) 2000-05-11
NZ511592A (en) 2002-09-27
KR100692720B1 (ko) 2007-03-09
AU754294B2 (en) 2002-11-14
NO327611B1 (no) 2009-08-31
JP2002528473A (ja) 2002-09-03
NO20011946L (no) 2001-04-19
EP1126785A4 (de) 2006-05-17
KR20010103622A (ko) 2001-11-23
WO2000025671A9 (en) 2000-10-26
DE69941029D1 (de) 2009-08-06

Similar Documents

Publication Publication Date Title
DE69941029D1 (de) Manganzusammensetzungen und verfahren für mri
DE69431660D1 (de) 2-pyridylmethylen-polyazamacrocyclophosphonsäuren, ihre komplexe und derivate zur verwendung als kontrastmittel
SG46496A1 (en) Tricyclopolyazamacrocyclophosphonic acids complexes and derivatives thereof for use as constrast agents
BG102729A (bg) Метод за дезактивиране на пепел
WO1997044063A3 (en) Dha-pharmaceutical agent conjugates
DE69527987D1 (de) Formulierungen und verfahren zur reduzierung von hautreizung
CA2400772A1 (en) Zinc finger domains and methods of identifying same
BG103977A (en) Low molecular rotamase enzymic activity inhibitors
TR199900308T2 (xx) Tiyenopirimidinler
DE69430951D1 (de) Zusammensetzung enthaltend bradykinin zum selektiven offnen von anormalen gehirngewebes kapillaren
ATE211135T1 (de) Aminocyclohexylester und ihre anwendung
ATE264859T1 (de) Neue adenosin-monophosphat-deaminase-inhibitoren
AU4064401A (en) Bile acids conjugates with metal ion chelates and the use thereof
CA2343130A1 (en) Cosmetic composition
ATE312876T1 (de) Verfahren zur verzögerung der abbaugeschwindigkeit von bioabbaubarem polymer und bioabbaubare polymerzusammensetzungen
ATE238814T1 (de) Dendrimere fullerenderivate, verfahren zur herstellung und verwendung als neuroprotektiva
EP1231274A3 (de) Modifizierte Protease-Inhibitoren
ATE201425T1 (de) Selektiv funktionalisierbare desdendrimere
MX9603602A (es) Anticuerpo especifico para fibrina para su uso como agente antitrombotico.
MXPA03001644A (es) Composiciones y metodos para el diagnostico y tratamiento de tumor.
BR9408021A (pt) Composição de condicionamento de tecido e uso de uma betaina de ácido alquil-amido-propil-dimetil-amino-acético
WO2002042262A3 (en) Alkylthio- and aryl(heteroyl)thio-substituted p-phenylenediamines, their manufacture and their use in rubber
EP0827505A4 (de) Ausgewählte lösliche ester von indolcarbazolen die hydroxyl enthalten
AU3703795A (en) Chondrocyte cell-lines
黄宏新 et al. Quantum Monte Carlo method of localized molecular orbitals

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties